Integer Holdings (ITGR) Stock Forecast & Price Target

Integer Holdings Corp has demonstrated robust financial performance and positive expectations for future growth, notably with a 15% revenue increase in the Cardio & Vascular segment in 3Q25, alongside a projected stable gross margin at approximately 27% in the coming years. The company anticipates revenues of $1.87 billion for 2026, marking a continuous upward trend, supported by expected operating cash flow improvements to between $230-$240 million in the current year. With a favorable outlook for the cardiovascular device market, driven by innovation and demographic trends, Integer is well-positioned to achieve above-market growth, thereby enhancing its financial stability and growth trajectory.

Integer Holdings Corp is facing a challenging financial outlook, with 4Q25 revenue estimates adjusted downward to $460 million, reflecting a modest 2% increase year-over-year, which is a decrease from previous estimates of $477 million. The company's management has also lowered its full-year 2026 organic revenue guidance to a range of flat to +3%, indicating weakened demand for its primary products and suggesting potential declines in revenue in the first half of 2026. Additionally, the ongoing sales challenges in the Other Markets segment, with an estimated decline of $30 to $35 million, further contribute to the negative outlook, emphasizing concerns over organic growth drivers and the possible risks associated with future mergers and acquisitions.